Arcus Biosciences, Inc. (RCUS)
22.61
-0.67
(-2.88%)
USD |
NYSE |
Apr 10, 14:56
Arcus Biosciences Profit Margin (Quarterly) : -321.2% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 27.44% |
| Merck & Co., Inc. | 18.15% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Regeneron Pharmaceuticals, Inc. | 21.74% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -67.06% |
| Return on Assets | -29.82% |
| Return on Invested Capital | -53.99% |
| Gross Profit Margin (Quarterly) | 90.91% |
| Operating Margin (Quarterly) | -345.5% |
| Return on Net Operating Assets | -426.3% |